Transition From Intravenous to Subcutaneous Insulin in Critically Ill Adults
Conclusions:
This retrospective study suggests critically ill adults may be safely transitioned to 50-59% of their 24-hour IV insulin requirements. A dosing protocol will be implemented to transition to 50-70% subcutaneous insulin. Follow-up data will be reviewed to assess the protocol’s safety and efficacy.
Source: Journal of Diabetes Science and Technology - Category: Endocrinology Authors: Doolin, M. K., Walroth, T. A., Harris, S. A., Whitten, J. A., Fritschle-Hilliard, A. C. Tags: Original Articles Source Type: research
More News: Burns | Computers | Diabetes | Endocrinology | Insulin | Intensive Care | Science | Study